Albendazole
- Generic Name
- Albendazole
- Brand Names
- Albenza
- Drug Type
- Small Molecule
- Chemical Formula
- C12H15N3O2S
- CAS Number
- 54965-21-8
- Unique Ingredient Identifier
- F4216019LN
- Background
A benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)
- Indication
For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.
- Associated Conditions
- Hydatid disease of the Liver, Hydatid disease of the Lung, Hydatid disease of the Peritoneum, Neurocysticercosis
- Associated Therapies
- -
A Pilot Study of Neurocysticercosis Treatment
- First Posted Date
- 2006-01-30
- Last Posted Date
- 2010-02-08
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 178
- Registration Number
- NCT00283699
- Locations
- 🇪🇨
Baca Ortiz Children's Hospital, Av. Colon s/n y 6 de Diciembre, Quito, Ecuador
🇪🇨Teodoro Maldonado Carbo Hospital, Av. 25 de Julio Vía Puerto Marítimo, Guayaquil, Ecuador
🇪🇨Hospital Eugenio Espejo, Servicio de Neurología, Av. Colombia s/n, Quito, Ecuador
Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2005-10-28
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 720000
- Registration Number
- NCT00222547
- Locations
- 🇮🇳
Shally Awasthi, Lucknow, Uttar Pradesh, India
RCT ALB for SA Cysticercosis
- Conditions
- Locations
- 🇨🇴
Instituto Neurologico de Antioquia, Medellin, Colombia
🇵🇪Universidad Peruana Cayetano Heredia, Lima, Peru
🇧🇷Facultad de Medicina de Riberao, Riberao Preto, Brazil
Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation
- Conditions
- Interventions
- First Posted Date
- 2005-08-16
- Last Posted Date
- 2007-11-15
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 234
- Registration Number
- NCT00130910
- Locations
- 🇰🇪
Kenya Medical Research Institute, Nairobi, Kenya
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- SmithKline Beecham
- Registration Number
- NCT00002191
- Locations
- 🇺🇸
George Washington Univ 5-403A, Washington, District of Columbia, United States
🇺🇸New York Univ, New York, New York, United States
🇺🇸Davies Med Ctr, San Francisco, California, United States
Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 120
- Registration Number
- NCT00004403
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.